{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:06:07Z","timestamp":1792307167136,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002257","name":"Nickel Producers Environmental Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bioorg.2023.106399","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:31:05Z","timestamp":1675045865000},"page":"106399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors"],"prefix":"10.1016","volume":"133","author":[{"given":"Sridhar Goud","family":"Nerella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavitra S.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Cancer J. Clinicians"},{"key":"10.1016\/j.bioorg.2023.106399_b0010","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2019.10","article-title":"Drug Resistance and Combating Drug Resistance in Cancer","author":"Wang","year":"2019","journal-title":"Cancer Drug Resistance"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small Molecules in Targeted Cancer Therapy: Advances, Challenges, and Future Perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduction Targeted Therapy"},{"issue":"14","key":"10.1016\/j.bioorg.2023.106399_b0020","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/cancers14143297","article-title":"Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside","volume":"14","author":"McDonald","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2023.106399_b0025","first-page":"1","article-title":"Anticancer Carbonic Anhydrase Inhibitors: A Patent and Literature Update 2018\u20132022","author":"Nerella","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.bioorg.2023.106399_b0035","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.2174\/1871520622666220304184525","article-title":"Synthesis and Biological Evaluation of Coumarin Carboxamides as Selective and Potent Inhibitors of Carbonic Anhydrases IX and XII","volume":"22","author":"Thacker","year":"2022","journal-title":"Anticancer Agents Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106399_b0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic Anhydrases An Overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106399_b0045","first-page":"1754","article-title":"Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents","volume":"20","author":"Goud","year":"2020","journal-title":"Anticancer Agents Medicinal Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2023.106399_b0050","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and Function of Carbonic Anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J"},{"key":"10.1016\/j.bioorg.2023.106399_b0055","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200232","article-title":"Synthesis and Biological Evaluation of Coumarin-thiazole Hybrids as Selective Carbonic Anhydrase IX and XII Inhibitors","author":"Thacker","year":"2022","journal-title":"Arch. Pharm."},{"issue":"23","key":"10.1016\/j.bioorg.2023.106399_b0060","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/ijms20236080","article-title":"Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX\/XII Inhibitors in the Treatment of Cancers","volume":"20","author":"Williams","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106399_b0065","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic Anhydrase Inhibitors: An Update on Experimental Agents for the Treatment and Imaging of Hypoxic Tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106399_b0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic Anhydrase Inhibitors and Their Potential in a Range of Therapeutic Areas","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0075","doi-asserted-by":"crossref","first-page":"15516","DOI":"10.1038\/s41598-021-94809-x","article-title":"Identification of Non-Classical HCA XII Inhibitors Using Combination of Computational Approaches for Drug Design and Discovery","volume":"11","author":"Al-Sanea","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106399_b0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer Carbonic Anhydrase Inhibitors: A Patent Review (2008\u20132013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"38","key":"10.1016\/j.bioorg.2023.106399_b0085","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal Structure of the Catalytic Domain of the Tumor-Associated Human Carbonic Anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.bioorg.2023.106399_b0090","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal Structure of the Dimeric Extracellular Domain of Human Carbonic Anhydrase XII, a Bitopic Membrane Protein Overexpressed in Certain Cancer Tumor Cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2023.106399_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105920","article-title":"A Decade of Tail-Approach Based Design of Selective as Well as Potent Tumor Associated Carbonic Anhydrase Inhibitors","volume":"126","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"34","key":"10.1016\/j.bioorg.2023.106399_b0100","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1021\/bi970760v","article-title":"Carbonic Anhydrase Activators: X-Ray Crystallographic and Spectroscopic Investigations for the Interaction of Isozymes I and II with Histamine","volume":"36","author":"Briganti","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2023.106399_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.812270","article-title":"PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective","volume":"9","author":"Nerella","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.bioorg.2023.106399_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103663","article-title":"Synthesis, 18F-Radiolabeling and Apoptosis Inducing Studies of Novel 4, 7-Disubstituted Coumarins","volume":"97","author":"Goud","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10967-021-07859-w","article-title":"Radiosynthesis of [18F]Flumazenil for Imaging Benzodiazepine Receptors and Its Evaluation in Human Volunteers Using Simultaneous PET-MRI","volume":"329","author":"Kumar","year":"2021","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.bioorg.2023.106399_b0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","article-title":"Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems","volume":"17","author":"Vaquero","year":"2015","journal-title":"Ann. Rev. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0971-6203.25665","article-title":"Positron Emission Tomography: An Overview","volume":"31","author":"Shukla","year":"2006","journal-title":"J. Med. Phys."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106399_b0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","article-title":"Positron Emission Tomography (PET) with 18F-Fluorodeoxyglucose (18F-FDG) for the Staging of Low-Grade Non-Hodgkin\u2019s Lymphoma (NHL)","volume":"12","author":"Jerusalem","year":"2001","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106399_b0135","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/acs.jmedchem.0c01053","article-title":"Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology","volume":"64","author":"Goud","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0140","first-page":"55","article-title":"Positron Emission Tomography (PET) Imaging with (18)F-Based Radiotracers","volume":"2","author":"Alauddin","year":"2012","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106399_b0145","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2174\/156802610791384261","article-title":"C-11 Radiochemistry in Cancer Imaging Applications","volume":"10","author":"Tu","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.ne.12.030189.001303","article-title":"Fluorescent Probes of Cell Signaling","volume":"12","author":"Tsien","year":"1989","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2023.106399_b0155","first-page":"1","article-title":"The Chemistry of Small-Molecule Fluorogenic Probes","volume":"Vol. 113","author":"Grimm","year":"2013"},{"issue":"30","key":"10.1016\/j.bioorg.2023.106399_b0160","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1039\/D0OB01131B","article-title":"Rational Design of Small Molecule Fluorescent Probes for Biological Applications","volume":"18","author":"Jun","year":"2020","journal-title":"Org. Biomol. Chem."},{"issue":"51","key":"10.1016\/j.bioorg.2023.106399_b0165","doi-asserted-by":"crossref","first-page":"29051","DOI":"10.1039\/C8RA02297F","article-title":"Small-Molecule Fluorescent Probes and Their Design","volume":"8","author":"Fu","year":"2018","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106399_b0170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nmeth.1663","article-title":"Fluorescent Probes for Sensing and Imaging","volume":"8","author":"Ueno","year":"2011","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106399_b0175","first-page":"865","article-title":"Conjugation of Fluorescein Isothiocyanate to Antibodies I. Experiments on the Conditions of Conjugation","volume":"18","author":"The","year":"1970","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-1759(81)90063-6","article-title":"A Simple Quantitative Immunofluorescence Assay for FITC-Labeled Antibody on Platelets","volume":"40","author":"Sugiura","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2023.106399_b0185","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications; Subcellular Biochemistry","first-page":"221","year":"2014"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2023.106399_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The Role of Carbonic Anhydrase IX in Cancer Development: Links to Hypoxia, Acidosis, and Beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioorg.2023.106399_b0195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bioorg.2019.04.004","article-title":"Synthesis and Biological Evaluation of Coumarin-1,3,4-Oxadiazole Hybrids as Selective Carbonic Anhydrase IX and XII Inhibitors","volume":"87","author":"Narella","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106399_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5306\/wjco.v3.i7.98","article-title":"Inhibition of Carbonic Anhydrase IX as a Novel Anticancer Mechanism","volume":"3","author":"Supuran","year":"2012","journal-title":"World J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106399_b0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic Anhydrase IX: Biochemical and Crystallographic Characterization of a Novel Antitumor Target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Proteins Proteomics"},{"key":"10.1016\/j.bioorg.2023.106399_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114190","article-title":"Discovery of New Carbonic Anhydrase IX Inhibitors as Anticancer Agents by Toning the Hydrophobic and Hydrophilic Rims of the Active Site to Encounter the Dual-Tail Approach","volume":"232","author":"Tawfik","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106399_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104204","article-title":"Pyridinium Derivatives of 3-Aminobenzenesulfonamide Are Nanomolar-Potent Inhibitors of Tumor-Expressed Carbonic Anhydrase Isozymes CA IX and CA XII","volume":"103","author":"Akocak","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106399_b0225","first-page":"2173","article-title":"Prognostic Value of Carbonic Anhydrase XII (CA XII) Overexpression in Hepatocellular Carcinoma","volume":"12","author":"Gu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"15","key":"10.1016\/j.bioorg.2023.106399_b0230","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug Design Studies of the Novel Antitumor Targets Carbonic Anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2023.106399_b0235","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.jmb.2019.10.022","article-title":"Biochemical and Structural Insights into Carbonic Anhydrase XII\/Fab6A10 Complex","volume":"431","author":"Alterio","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2023.106399_b0240","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New Anticancer Drug Candidates Sulfonamides as Selective HCA IX or HCA XII Inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0245","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","article-title":"Targeting Carbonic Anhydrase IX and XII Isoforms with Small Molecule Inhibitors and Monoclonal Antibodies","volume":"37","author":"Kciuk","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106399_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104272","article-title":"Synthesis and Biological Evaluation of Some Coumarin Hybrids as Selective Carbonic Anhydrase IX and XII Inhibitors","volume":"104","author":"Thacker","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bc500475e","article-title":"Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes","volume":"26","author":"Jacobson","year":"2015","journal-title":"Bioconjugugate Chem."},{"key":"10.1016\/j.bioorg.2023.106399_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111979","article-title":"Fluorine-18: A Radionuclide with Diverse Range of Radiochemistry and Synthesis Strategies for Target Based PET Diagnosis","volume":"187","author":"Goud","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106399_b0265","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2174\/1568026614666140202205035","article-title":"Radiosyntheses Using Fluorine-18: The Art and Science of Late Stage Fluorination","volume":"14","author":"Cole","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The Role of Fluorine in Medicinal Chemistry: Review Article","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0275","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1874471014666210129141221","article-title":"Automated Radiosynthesis and Molecular Docking Studies of Coumarin-Triazole Hybrid with Fluorine-18: A Feasibility Study","volume":"15","author":"Goud","year":"2022","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.bioorg.2023.106399_b0280","series-title":"Handbook of Radiopharmaceuticals","first-page":"251","article-title":"Fluorine\u201018 Radiochemistry","author":"Brooks","year":"2020"},{"key":"10.1016\/j.bioorg.2023.106399_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113046","article-title":"Radiotracers for Positron Emission Tomography (PET) Targeting Tumour-Associated Carbonic Anhydrase Isoforms","volume":"213","author":"Burianova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1874471011003020068","article-title":"Fluorine-18 Chemistry for PET: A Concise Introduction","volume":"3","author":"Banister","year":"2010","journal-title":"Curr. Radiopharm."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0295","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/cr941145p","article-title":"Electrophilic NF Fluorinating Agents","volume":"96","author":"Lal","year":"1996","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106399_b0300","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2174\/156802610791384298","article-title":"PET Designated Flouride-18 Production and Chemistry","volume":"10","author":"Jacobson","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106399_b0305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0883-2889(86)90262-5","article-title":"Chemistry of Fluorine-18 Radiopharmaceuticals. International Journal of Radiation Applications and Instrumentation. Part A","volume":"37","author":"Berridge","year":"1986","journal-title":"Appl. Radiat. Isot."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106399_b0310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acscentsci.6b00061","article-title":"Moving Metal-Mediated 18 F-Fluorination from Concept to Clinic","volume":"2","author":"Sanford","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2023.106399_b0315","series-title":"Organic Reactions","first-page":"1","article-title":"Transition-Metal-Mediated and Transition-Metal-Catalyzed Carbon-Fluorine Bond Formation","author":"Neumann","year":"2020"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s41181-021-00143-y","article-title":"Closing the Gap between 19F and 18F Chemistry","volume":"6","author":"Ajenjo","year":"2021","journal-title":"EJNMMI Radiopharm. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106399_b0325","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13543776.2022.2032649","article-title":"Synthetic Methodologies and PET Imaging Applications of Fluorine-18 Radiotracers: A Patent Review","volume":"32","author":"Nerella","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0330","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11307-015-0831-y","article-title":"[18F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models","volume":"17","author":"Peeters","year":"2015","journal-title":"Mol. Imag. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0335","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11307-014-0730-7","article-title":"Biodistribution and Radiation Dosimetry of the Carbonic Anhydrase IX Imaging Agent [18F]VM4-037 Determined from PET\/CT scans in Healthy Volunteers","volume":"16","author":"Doss","year":"2014","journal-title":"Mol. Imaging Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0340","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/14756366.2017.1308928","article-title":"Design, Synthesis and Evaluation of 18F-Labeled Cationic Carbonic Anhydrase IX Inhibitors for PET Imaging","volume":"32","author":"Zhang","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0345","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bmc.2019.01.014","article-title":"Fluorine-18 Click Radiosynthesis and MicroPET\/CT Evaluation of a Small Peptide-a Potential PET Probe for Carbonic Anhydrase IX","volume":"27","author":"Jia","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106399_b0350","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/RLU.0000000000003914","article-title":"Imaging of Tumor Hypoxia With 18F-EF5 PET\/MRI in Cervical Cancer","volume":"46","author":"Narva","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0355","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bmcl.2018.01.060","article-title":"Acetazolamide-Based [18 F]-PET Tracer. In Vivo Validation of Carbonic Anhydrase IX as a Sole Target for Imaging of CA-IX Expressing Hypoxic Solid Tumors","volume":"28","author":"More","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/14756366.2013.773994","article-title":"Synthesis and Evaluation of 18 F-Labeled Carbonic Anhydrase IX Inhibitors for Imaging with Positron Emission Tomography","volume":"29","author":"Pan","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2023.106399_b0365","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1016\/j.bmcl.2014.05.021","article-title":"Synthesis and Evaluation of 18F-Labeled Tertiary Benzenesulfonamides for Imaging Carbonic Anhydrase IX Expression in Tumours with Positron Emission Tomography","volume":"24","author":"Lau","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0370","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0969-8043(02)00184-7","article-title":"Distribution of 16\u03b1-[18F]Fluoro-Estradiol-3,17\u03b2-Disulfamate in Rats, Tumour-Bearing Mice and Piglets","volume":"57","author":"Brust","year":"2002","journal-title":"Appl. Radiat. Isot."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106399_b0375","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2967\/jnumed.114.153288","article-title":"Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX\u2013Targeted PET Imaging","volume":"56","author":"Lau","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2023.106399_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109486","article-title":"Radiosynthesis Challenges of 11C and 18F-Labeled Radiotracers in the FX2C\/N Tracerlab and Their Validation through PET-MR Imaging","volume":"168","author":"Joshi","year":"2021","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.bioorg.2023.106399_b0385","series-title":"Radiopharmaceutical Chemistry","first-page":"207","article-title":"The Radiopharmaceutical Chemistry of Carbon-11: Basic Principles","author":"Antoni","year":"2019"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106399_b0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40336-017-0223-1","article-title":"New Methodologies for the Preparation of Carbon-11 Labeled Radiopharmaceuticals","volume":"5","author":"Dahl","year":"2017","journal-title":"Clin. Trans. Imaging"},{"key":"10.1016\/j.bioorg.2023.106399_b0395","first-page":"1","article-title":"Carbon-11 Patents (2012\u20132022): Synthetic Methodologies and Novel Radiotracers for PET Imaging","author":"Nerella","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106399_b0400","series-title":"PET Chemistry. Ernst Schering Research Foundation Workshop","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-540-49527-7_7","article-title":"Carbon-11 Labeling Chemistry Based upon [11C]Methyl Iodide","author":"Wuest","year":"2007"},{"issue":"23","key":"10.1016\/j.bioorg.2023.106399_b0405","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1016\/j.bmcl.2011.09.102","article-title":"Radiosynthesis of Three [11C]Ureido-Substituted Benzenesulfonamides as PET Probes for Carbonic Anhydrase IX in Tumors","volume":"21","author":"Asakawa","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106399_b0410","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0883-2889(88)90056-1","article-title":"The Radiosynthesis of a 11C-Labelled Carbonic Anhydrase Inhibitor\u2014[Carbonyl-11C]Acetazolamide","volume":"39","author":"Le Bars","year":"1988","journal-title":"Int. J. Radiation Appl. Instrument. Part A Appl. Radiat. Isot."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106399_b0415","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.7150\/thno.21848","article-title":"Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX","volume":"7","author":"Lau","year":"2017","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106399_b0420","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1039\/C4DT03206C","article-title":"Synthesis of Sulfonamide Conjugates of Cu(ii), Ga(iii), In(iii), Re(v) and Zn(ii) Complexes: Carbonic Anhydrase Inhibition Studies and Cellular Imaging Investigations","volume":"44","author":"Dilworth","year":"2015","journal-title":"Dalton Trans."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106399_b0425","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acs.molpharmaceut.5b00934","article-title":"PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with 68 Ga-Labeled Benzenesulfonamides","volume":"13","author":"Lau","year":"2016","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.bioorg.2023.106399_b0430","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","article-title":"Synthesis and in Vivo Biological Evaluation of 68 Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography","volume":"59","author":"Sneddon","year":"2016","journal-title":"J. Med. Chem."},{"issue":"35","key":"10.1016\/j.bioorg.2023.106399_b0435","doi-asserted-by":"crossref","first-page":"56471","DOI":"10.18632\/oncotarget.10602","article-title":"[64Cu]XYIMSR-06: A Dual-Motif CAIX Ligand for PET Imaging of Clear Cell Renal Cell Carcinoma","volume":"7","author":"Minn","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106399_b0440","first-page":"379","article-title":"Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"issue":"15","key":"10.1016\/j.bioorg.2023.106399_b0445","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic Anhydrase Inhibitors. Design of Fluorescent Sulfonamides as Probes of Tumor-Associated Carbonic Anhydrase IX That Inhibit Isozyme IX-Mediated Acidification of Hypoxic Tumors","volume":"48","author":"Cecchi","year":"2005","journal-title":"J. Med. Chem."},{"issue":"29","key":"10.1016\/j.bioorg.2023.106399_b0450","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1039\/c1cc12386f","article-title":"A Highly Selective Space-Folded Photo-Induced Electron Transfer Fluorescent Probe for Carbonic Anhydrase Isozymes IX and Its Applications for Biological Imaging","volume":"47","author":"Zhang","year":"2011","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0455","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bmcl.2011.10.058","article-title":"Synthesis and Evaluation of Near-Infrared Fluorescent Sulfonamide Derivatives for Imaging of Hypoxia-Induced Carbonic Anhydrase IX Expression in Tumors","volume":"22","author":"Groves","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.bioorg.2023.106399_b0460","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","article-title":"In Vivo Targeting of Tumor-Associated Carbonic Anhydrases Using Acetazolamide Derivatives","volume":"19","author":"Ahlskog","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106399_b0465","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1078-0432.CCR-11-0238","article-title":"Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes","volume":"18","author":"Tafreshi","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106399_b0470","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-013-2635-6","article-title":"Molecular Imaging with a Fluorescent Antibody Targeting Carbonic Anhydrase IX Can Successfully Detect Hypoxic Ductal Carcinoma in Situ of the Breast","volume":"140","author":"van Brussel","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bioorg.2023.106399_b0475","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jmgm.2014.10.010","article-title":"Identifying Potential Selective Fluorescent Probes for Cancer-Associated Protein Carbonic Anhydrase IX Using a Computational Approach","volume":"54","author":"Kamstra","year":"2014","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106399_b0480","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1021\/acs.molpharmaceut.6b00065","article-title":"Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors","volume":"13","author":"Lv","year":"2016","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106399_b0485","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/acs.bioconjchem.8b00509","article-title":"Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic Tumors","volume":"29","author":"Mahalingam","year":"2018","journal-title":"Bioconjugate Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106399_b0490","doi-asserted-by":"crossref","first-page":"e50860","DOI":"10.1371\/journal.pone.0050860","article-title":"In Vivo Imaging and Quantification of Carbonic Anhydrase IX Expression as an Endogenous Biomarker of Tumor Hypoxia","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bioorg.2023.106399_b0495","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.3390\/ijms23116125","article-title":"New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106399_b0500","unstructured":"V. De Franciscis, C.L. Esposito et al., Ca-IX Aptamers and Diagnostic and Therapeutic Uses Thereof. WO 2021\/052982 Al, 2021."},{"key":"10.1016\/j.bioorg.2023.106399_b0505","unstructured":"H. Kolb, J.C. Walsh et al., Development of molecular imaging probes for carbonic anhydrase -IX using click chemistry, Wo2008\/124703 A3, 2008."},{"key":"10.1016\/j.bioorg.2023.106399_b0510","unstructured":"X. Yang, I. Minn et al., Nuclear Imaging and Radiotherapeutics Agents Targeting Carbonic Anhydrase IX and Uses Thereof, WO\/2017\/197251, 2017."},{"key":"10.1016\/j.bioorg.2023.106399_b0515","unstructured":"P.S. Low, S.M. Mahalingam et al., Ca IX-Target Nir Dyes and Their Uses, WO 2017\/161195 Al, 2017."},{"key":"10.1016\/j.bioorg.2023.106399_b0520","unstructured":"L. Gualandi, S. Wulhfard, Antibodies to Tumour Antigens, EP3502139A1, 2019."},{"key":"10.1016\/j.bioorg.2023.106399_b0525","unstructured":"S.S. Guan, T.Y. Luo, Dual-Targeted Carbonic Anhydrase Ix Complex and Contrast Agent Thereof, US 2021\/0154334 Al, 2021."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:38:51Z","timestamp":1758616731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":105,"alternative-id":["S0045206823000597"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106399","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106399"}}